Adlai Nortye (ANL) Total Current Liabilities (2022 - 2025)

Adlai Nortye's (ANL) quarterly Total Current Liabilities came in at $41.6 million in Q4 2025, down 8.23% year-on-year from $45.4 million in Q4 2024, and down 34.82% on a QoQ basis from $63.9 million in Q2 2025.

Adlai Nortye (ANL) Total Current Liabilities (2022 - 2025) Analysis & Trends

Adlai Nortye (ANL) has 4 years of Total Current Liabilities data on file, last reported at $41.6 million in Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 8.23% year-over-year to $41.6 million in Q4 2025; TTM through Dec 2025 was $41.6 million, a 8.23% decrease from a year earlier, with the FY2025 full-year figure at $41.6 million, down 8.23% from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $41.6 million, down from $63.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for ANL reached as high as $312.7 million in Q4 2022 and fell as low as $41.6 million in Q4 2025.
  • Historically, Total Current Liabilities has averaged $94.6 million across 4 years, with a median of $52.0 million in 2023.
  • Across the five-year window, Total Current Liabilities slumped 84.11% in 2023 and rose 17.59% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $312.7 million in 2022, then slumped by 84.11% to $49.7 million in 2023, then slipped by 8.68% to $45.4 million in 2024, then retreated by 8.23% to $41.6 million in 2025.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $41.6 million in Q4 2025, $63.9 million in Q2 2025, and $45.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 56.01 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 289.60 Mn
10 Adlai Nortye 1.16 Bn 1.15 Bn - 41.63 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 41.63 Mn
Jun 30, 2025 63.87 Mn
Dec 31, 2024 45.36 Mn
Jun 30, 2024 54.31 Mn
Dec 31, 2023 49.67 Mn
Dec 31, 2022 312.65 Mn